• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
GAO Qi, HAN Yue, XU Wei, XU Jingjing, WANG Min, ZHANG Juan. Combination of a single-chain variable fragment JZC00 with 2-deoxyglucose inhibited tumor growth in murine models[J]. Journal of China Pharmaceutical University, 2020, 51(2): 206-212. DOI: 10.11665/j.issn.1000-5048.20200212
Citation: GAO Qi, HAN Yue, XU Wei, XU Jingjing, WANG Min, ZHANG Juan. Combination of a single-chain variable fragment JZC00 with 2-deoxyglucose inhibited tumor growth in murine models[J]. Journal of China Pharmaceutical University, 2020, 51(2): 206-212. DOI: 10.11665/j.issn.1000-5048.20200212
shu

Combination of a single-chain variable fragment JZC00 with 2-deoxyglucose inhibited tumor growth in murine models

More Information
    Graphical Abstract
    • Abstract
  • This study aimed to investigate the antitumor efficacy of a single-chain variable fragment JZC00 combined with 2-deoxyglucose(2-DG)on murine non-small lung cancer cell and breast cancer cell models. JZC00 was expressed by E. coli and identified using SDS-PAGE and Western blot. The combination inhibited the proliferation of LLC and 4T1 cells. The concentration of glucose and lactic acid in the medium were determined by glucose and lactate kit, respectively, then calculated the tumor cell glucose uptake inhibition rate and lactate release inhibition rate. In vivo, the tumor volume and tumor weight were analyzed after 15-day treatment. The results showed that the molecular weight of JZC00 expressed was correct, and it could inhibit the proliferation of tumor cells in vitro. JZC00 and 2-DG could inhibit the glycolysis of tumor cells, respectively, and JZC00 combined with 2-DG could inhibit glycolysis synergistically. When hypoxic microenvironment was induced in vitro, the inhibition of glycolysis by JZC00 treatment decreased. However, it was reversed with the addition of 2-DG. The in vivo models the combination showed a significantly improved tumor suppressive effect compared with JZC00 treated group, suggesting that 2-DG could improve the anti-tumor effect of anti-angiogenic antibodies and its combination has the potentialial value in the treatment of solid tumors.
    • FullText(HTML)
    • References (19)
  • [1]
    Zhang WL,Wang XY,Yan F.Advances of relationship between protein O-GlcNAcylation and glucose metabolism in tumors[J].J China Pharm Univ(中国药科大学学报),2019,50(2):7-14.
    [2]
    Kuczynski EA,Ermeulen PB,Pezzella F,et al.Vessel co-option in cancer[J].Nat Rev Clin Oncol,2019,16(8):469-493.
    [3]
    Ferrara N,Kerbel RS.Angiogenesis as a therapeutic target[J].Nature,2005,438(7070):967-974.
    [4]
    Carmeliet P,Jain RK.Molecular mechanisms and clinical applications of angiogenesis[J].Nature,2011,473(7347):298-307.
    [5]
    Roskoski R.Vascular endothelial growth factor(VEGF)signaling in tumor progression[J].Crit Rev Oncol Hematol,2007,62(3):179-213.
    [6]
    Simon T,Gagliano T,Giamas G.Direct effects of anti-angiogenic therapies on tumor cells:VEGF signaling[J].Trends Mol Med,2017,23(3):282-292.
    [7]
    Fuchs CS,Tabernero J,Tomásek J,et al.Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab[J].Br J Cancer,2016,115(8):974-982.
    [8]
    Allen E,Jabouille A,Rivera LB,et al.Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation[J].Sci Transl Med,2017,9(385):eaak9679.
    [9]
    Urakami K, Zangiacomi V, Yamaguchi K, et al. Impact of 2-deoxy-D-glucose on the target metabolome profile of a human endometrial cancer cell line[J].Biomed Res,2013,34(5):221-229.
    [10]
    Zaira L,Wiek P,Valeriya D,et al.2-Deoxy-D-glucose restore glucocorticoid sensitivity in acute lymphoblastic leukemia via modification of N-Linked glycosylation in an oxygen tension-independent manner[J].Oxid Med Cell Longev,2017,2017:1-15.
    [11]
    Zagorodna O,Martin SM,Rutkowski DT,et al.2-Deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines[J].Oncogene,2012,31(22):2738-2749.
    [12]
    Golding JP, Wardhaugh T, Patrick L, et al. Targeting tumour energy metabolism potentiates the cytotoxicity of 5-aminolevulinic acid photodynamic therapy[J].Br J Cancer,2013,109(4):976-982.
    [13]
    Zhang SQ,Yung KLK,Chung SK,et al.Aldo-Keto reductases mediated cytotoxicity of 2-deoxyglucose:a novel anticancer mechanism[J].Cancer Sci,2018,109:1970-1980.
    [14]
    Huang CC,Wang S,Lin LL,et al.Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in mice[J].Dis Model Mech,2015,8(10):1247-1254.
    [15]
    Zhang J,Li H,Wang X,et al.Phage-derived fully human antibody scFv fragment directed against human vascular endothelial growth factor receptor 2 blocked its interaction with VEGF[J].Biotechnol Progr,2012,28(4):981-989.
    [16]
    Xie W,Li D,Zhang J,et al.Generation and characterization of a novel human IgG1 antibody against vascular endothelial growth factor receptor 2[J].Cancer Immunol Immunother,2014,63(9):877-888.
    [17]
    Sun Q,Chen X,Ma J,et al.Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth[J].Proc Natl Acad Sci U S A,2011,108(10):4129-4134.
    [18]
    Rapisarda A,Melillo G.Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia[J].Nat Rev Clin Oncol,2012,9(7):378-390.
    [19]
    Zhao Y,Liu H,Liu Z,et al.Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism[J].Cancer Res,2011,71(13):4585-4597.
    • Related Articles

  • Related Articles

    [1]DU Lixia, LI Dian, ZHUO Huirong, SHI Mengnan, CHEN Yanning, LI Lanfang, HOU Shaoyang. Primer probes for targeted identification and detection of Bifidobacterium animalis and their application[J]. Journal of China Pharmaceutical University, 2023, 54(2): 255-262. DOI: 10.11665/j.issn.1000-5048.20220912001
    [2]Near-infrared Diffuse Reflectance Spectroscopy Visualization Convolution Fingerprint Diagram in the Qualitative Identification for Chinese Traditional Medicines[J]. Journal of China Pharmaceutical University, 2003, (2): 9-12.
    [3]Morphological and Histological Identification of Chinese Crude Drug Shanziwan (The Radix and Rhizome of Ligularia ) (Ⅰ)[J]. Journal of China Pharmaceutical University, 1997, (1): 11-16.
    [4]Identification of Pearl Powder and Pearl Layer Powder by DSC[J]. Journal of China Pharmaceutical University, 1996, (6): 61-62.
    [5]Research on the Identification of Herba Sedi and the other Five Species of Sedum[J]. Journal of China Pharmaceutical University, 1996, (6): 15-19.
    [6]Studies on the IR Spectra of Thirty Species of Authentic Plant Drugs[J]. Journal of China Pharmaceutical University, 1996, (1): 24-28.
    [7]Investigation and Identification of Traditional Chinese Medicinal Materials Aci Pulvis[J]. Journal of China Pharmaceutical University, 1996, (1): 4-5.
    [8]Early Identification of Macrolide Antibiotic M-90[J]. Journal of China Pharmaceutical University, 1993, (3): 168-173.
    [9]MICROSCOPICAL IDENTIFICATION OF POWDERED ANIMAL DRUGS[J]. Journal of China Pharmaceutical University, 1985, (4): 27-34.
    [10]Song Xuehua, Xu Guojun, Jin Rongluan, Xu Luoshan. STUDIES ON THE IDENTIFICATION OF THE CHINESE DRUGS WUJIAPI[J]. Journal of China Pharmaceutical University, 1983, (1): 15-24+80.

Catalog

    Get Citation
    PDF
    XML
    Article views (372) PDF downloads (772) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：315997

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return